News
COVID, Moderna and FDA
Digest more
The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
Moderna shares surged 9.5% amid legal backlash against vaccine policy changes. Will it be a turning point for MRNA which is ...
Pfizer and Moderna will now include more information on the risk of myocarditis on their COVID-19 vaccine labels.
Moderna Inc. jumped by 8.83 percent on Tuesday to close at $32.54 apiece as investor sentiment was boosted by a lawsuit filed ...
4d
Barchart on MSNThe Next Moderna? This Clinical-Stage Biotech Has Breakout Potential.Moderna (MRNA), an undervalued name in the biotech space, rose to prominence during the COVID-19 pandemic. This occurred when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results